Skip to main content
Anthony Chiurco, MD, Neurosurgery, Lawrenceville, NJ

AnthonyAlfredChiurcoMD

Neurosurgery Lawrenceville, NJ

Assistant Clinical Professor of Neurological Surgery

Dr. Chiurco is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chiurco's full profile

Already have an account?

  • Office

    3131 Princeton Pike
    Building 4, Suite 201
    Lawrenceville, NJ 08648
    Phone+1 609-895-8898
    Fax+1 609-895-8330

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Neurological Surgery, 1971 - 1975
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Surgery, 1970 - 1971
  • Presbyterian Medical Center of the University of Pennsylvania Health System
    Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 1967 - 1968
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1967

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1976 - 2025
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FAANS) American Association of Neurological Surgeons

Press Mentions

  • Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research
    Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer ResearchJanuary 26th, 2021
  • Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed Glioblastoma
    Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed GlioblastomaApril 20th, 2019

Professional Memberships